TherapeuticsMD

TXMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$20.024 M

$1.73 -4.95%

Close of 6 Nov 2026

As of 6 Nov 2026, TherapeuticsMD (TXMD) has a market capitalization of $20.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.76M

#3412 by revenue

Earnings

-$569.0K

Loss-making

Shares outstanding

11,574,362

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#382ImmutepIMMP$20.6M
#383Atossa TherapeuticsATOS$20.1M
#384TherapeuticsMDTXMD$20.0M
#385Aytu BiopharmaAYTU$19.9M
#386Cocrystal PharmaCOCP$19.5M

What if TherapeuticsMD were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,439,605

Per share 1,410,176× higher

Bitcoin $1.53T

$132,002.79

Per share 76,302× higher

Apple $5.02T

$433,352.84

Per share 250,493× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for TherapeuticsMD are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.